Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.92 Billion | 3.04 Billion | 2.54 Billion | 2.19 Billion | 1.68 Billion | 1.38 Billion |
| Cost of Revenue | 1.17 Billion | 906.2 Million | 734.3 Million | 500.86 Million | 337 Million | 265.47 Million |
| Gross Profit | 2.75 Billion | 2.14 Billion | 1.81 Billion | 1.69 Billion | 1.34 Billion | 1.11 Billion |
| Operating Expenses | 971.76 Million | 772.58 Million | 723.93 Million | 619.57 Million | 477.23 Million | 348.97 Million |
| Selling, General and Administrative Expenses | 282.09 Million | 496.26 Million | 399.79 Million | 324.53 Million | 351.27 Million | 268.65 Million |
| Research and Development Expenses | 366.04 Million | 317.71 Million | 215.04 Million | 150.58 Million | 119.59 Million | 84.24 Million |
| Other Expenses | -141.66 Million | -41.38 Million | 109.09 Million | 144.44 Million | 6.37 Million | -576.87 Thousand |
| Cost and Expenses | 2.03 Billion | 1.67 Billion | 1.45 Billion | 1.12 Billion | 814.23 Million | 614.45 Million |
| Operating Income | 1.89 Billion | 1.5 Billion | 1.13 Billion | 1.09 Billion | 898.92 Million | 807.76 Million |
| Interest Expense | 434.21 Thousand | 274.74 Thousand | 152.66 Thousand | 1.14 Million | - | 1.15 Million |
| Income Tax Expense | 239.41 Million | 173.28 Million | 161.83 Million | 157.61 Million | 125.85 Million | 113.19 Million |
| Earnings before Tax | 1.89 Billion | 1.5 Billion | 1.13 Billion | 1.09 Billion | 898.46 Million | 807.19 Million |
| Net Income | 1.65 Billion | 1.32 Billion | 973.69 Million | 939.14 Million | 772.6 Million | 693.99 Million |
| Earnings Per Share Basic | 2.10 | 1.69 | 1.24 | 1.20 | 0.99 | 0.99 |
| Earnings Per Share Diluted | 2.10 | 1.69 | 1.24 | 1.20 | 0.99 | 0.99 |
| Weighted Average Shares Outstanding | 785.71 Million | 785.71 Million | 783.97 Million | 782.03 Million | 782.03 Million | 703.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 785.84 Million | 786.35 Million | 785.99 Million | 782.03 Million | 782.03 Million | 703.77 Million |
| Gross Margin | 0.70 | 0.70 | 0.71 | 0.77 | 0.80 | 0.81 |
| EBIT Margin | 0.53 | 0.53 | 0.47 | 0.53 | 0.56 | 0.62 |
| Profit Margin | 0.42 | 0.44 | 0.38 | 0.43 | 0.46 | 0.50 |
| EBITDA | 2.07 Billion | 1.63 Billion | 1.24 Billion | 1.18 Billion | 958.1 Million | 847.92 Million |
| Earnings Before Tax Margin | 0.48 | 0.49 | 0.45 | 0.50 | 0.53 | 0.58 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 1.18 Billion | 1.01 Billion | 1.01 Billion | 3.91 Billion | 1.04 Billion |
| Cost of Revenue | 338.74 Million | 367.16 Million | 267.25 Million | 289.82 Million | 1.17 Billion | 267.35 Million |
| Gross Profit | 864.59 Million | 817.41 Million | 749.99 Million | 727.71 Million | 2.74 Billion | 775.56 Million |
| Operating Expenses | 345.67 Million | 283.27 Million | 298.33 Million | 229.78 Million | 1 Billion | 292.21 Million |
| Selling, General and Administrative Expenses | 472.93 Million | 190.58 Million | 196.88 Million | 143.78 Million | - | 223.67 Million |
| Research and Development Expenses | 123.04 Million | 92.68 Million | 101.45 Million | 86 Million | - | 99.26 Million |
| Other Expenses | -250.3 Million | -17.78 Million | -306.26 Thousand | -777.18 Thousand | -2.12 Million | -90.9 Thousand |
| Cost and Expenses | 684.41 Million | 650.43 Million | 565.59 Million | 519.6 Million | 2.17 Billion | 559.56 Million |
| Operating Income | 543.38 Million | 534.14 Million | 451.66 Million | 497.92 Million | 1.73 Billion | 501.42 Million |
| Interest Expense | 115.56 Thousand | 116.24 Thousand | 78.63 Thousand | 90.68 Thousand | 434.21 Thousand | 172.9 Thousand |
| Income Tax Expense | 63.23 Million | 76.89 Million | 60.25 Million | 60.5 Million | 239.41 Million | 64.62 Million |
| Earnings before Tax | 543.67 Million | 553.82 Million | 486.48 Million | 527.45 Million | 1.89 Billion | 501.33 Million |
| Net Income | 480.44 Million | 476.92 Million | 426.22 Million | 466.94 Million | 1.65 Billion | 436.7 Million |
| Earnings Per Share Basic | 0.61 | 0.61 | 0.54 | 0.59 | - | 0.56 |
| Earnings Per Share Diluted | 0.61 | 0.61 | 0.54 | 0.59 | - | 0.56 |
| Weighted Average Shares Outstanding | 785.71 Million | 785.71 Million | 785.71 Million | 785.71 Million | 785.71 Million | 785.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 785.71 Million | 785.71 Million | 785.71 Million | 785.71 Million | 785.84 Million | 785.71 Million |
| Gross Margin | 0.72 | 0.69 | 0.74 | 0.72 | 0.70 | 0.74 |
| EBIT Margin | 0.45 | 0.50 | 0.48 | 0.54 | - | 0.46 |
| Profit Margin | 0.40 | 0.40 | 0.42 | 0.46 | 0.42 | 0.42 |
| EBITDA | 543.79 Million | 586.9 Million | 487.55 Million | 547.56 Million | - | 482.26 Million |
| Earnings Before Tax Margin | 0.45 | 0.45 | 0.44 | 0.49 | 0.44 | 0.48 |
5257
1277
200670
CLEU
8623
3825